Mizuho Begins Coverage on Tandem Diabetes Care (NASDAQ:TNDM)

Mizuho started coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) in a report issued on Thursday, MarketBeat Ratings reports. The brokerage issued a neutral rating and a $20.00 target price on the medical device company’s stock. Other equities research analysts also recently issued research reports about the company. Sanford C. Bernstein downgraded […]